abstract |
The present invention relates to a novel Enterococcus faecium L11 strain and a prodrug composition containing the same as an active ingredient. The Enterococcus faecium L11 strain or its culture according to the present invention has antimicrobial effect against various pathogenic microorganisms and is excellent in acid resistance, artificial gastric tolerance, biliary properties and immunity enhancing effect, so that it can be used as a probiotic agent, a medicament, a health food, , Feed additives, and the like. |